Boston - Events at Quotient Sciences

ISSX Conference 2023 | Boston, MA

Boston, MA, USA | 10 September 2023 - 13 September 2023
About Iain Shaw: Senior Director, 14C Enabled Drug Development

Iain Shaw is Senior Director of 14C Enabled Drug Development at Quotient Sciences. Iain has over 30 years of experience in the pharmaceutical industry, including more than 20 years of drug development experience.  


Scientific Poster Spotlight: Understanding the Absorption, Metabolism, and Excretion of Masitinib in Healthy Male Subjects

At the International Society for the Study of Xenobiotics (ISSX) conference in September 2022, Quotient Sciences, AB Science, the Netherlands Organisation for Applied Scientific Research (TNO), and Pharmaron presented a poster investigating the absorption, metabolism, and excretion (ADME) of masitinib, an oral tyrosine-kinase inhibitor that targets mast cells and macrophages and is currently in development as a potential treatment for neurology, inflammatory diseases, oncology, and viral diseases. 

Random Hotel
Boston, MA, USA

In attendance

General content block. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod.

Dr. Asma Patel

VP, Integrated Development Services

Dr. Asma Patel is VP of Integrated Development Services at Quotient Sciences. In this role, Asma is responsible for providing scie...

About Asma
Join us in Boston